Complementary therapies: Evaluating their effectiveness in cancer

Patient Education and Counseling

Volumn 38, Issue 2, 1999, Pages 101-108

  Hilsden, Robert J ^a   Verhoef, Marja J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cancer; Complementary and alternative medicine; randomized controlled trials

Indexed keywords

PLACEBO;

ALTERNATIVE MEDICINE; CANCER; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; EQUIPMENT; EVIDENCE BASED MEDICINE; METHODOLOGY; MORTALITY; NEEDS ASSESSMENT; NEOPLASM; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SAFETY; STANDARD; SURVIVAL; TREATMENT OUTCOME;

COMPLEMENTARY THERAPIES; EFFECT MODIFIERS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; HUMANS; NEEDS ASSESSMENT; NEOPLASMS; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAFETY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032821614     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(99)00057-9     Document Type: Article

References (41)

1. Lerner I.J., Kennedy B.J. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin. 42:1992;181-191.
2. Risberg T., Lund E., Wist E., Kaasa S., Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol. 16:1998;6-12.
3. Verhoef M.J., Hilsden R.J., O'Beirne M. Complementary and alternative therapies and cancer care: an overview. Patient Educ Couns. 38:1999;93-100.
4. A guide to unconventional cancer therapies. first ed :1994;Ontario Breast Cancer Information Exchange Project, Toronto.
5. Lerner I.J. Against nonscientific treatments. J Lab Clin Med. 127:1996;242-243.
6. Tannock I.F., Warr D.G. Unconventional therapies for cancer: a refuge from the rules of evidence? Can Med Assoc J. 159:1998;801-802.
7. Bourgeault I.L. Physicians' attitudes towards patients' use of alternative cancer therapies. Can Med Assoc J. 155:1996;1679-1685.
8. Coppes M.J., Anderson R.A., Egeler R.M., Wolff J.E. Alternative therapies for the treatment of childhood cancer. N Engl J Med. 339:1998;846-847.
9. Montbriand M.J. Abandoning biomedicine for alternate therapies: oncology patients' stories. Cancer Nurs. 21:1998;36-45.
10. Gerson Institute, http://www.gerson.org/welcome.htm (accessed 01/25/95).
11. Original Hoxsey herbal treatment at Bio-Medical Center, http://members.tripod.com/~hoxsey/ (accessed 01/25/99).
12. Burzynski Research Institute Clinical Trials Home Page http://www.cancermed.com/ (accessed 01/25/99).
13. Aakster C.W. Concepts in alternative medicine. Soc Sci Med. 22:1986;265-273.
14. Micozzi M.S. Characteristics of complementary and alternative medicine. Micozzi S. Fundamentals of complementary and alternative medicine. 1996;3-8 Churchill Livingstone, New York.
15. Dunne R., Watkins J. Complementary medicine - some definitions. J Roy Soc Health. 117:1997;287-291.
16. The physician and unorthodox cancer therapies. J Clin Oncol. 15:1997;401-406.
17. Friedman L.M., Furberg C.D., DeMets D.L. Introduction to clinical trials. Fundamentals of clinical trials. third ed :1996;1-15 Mosby, St. Louis.
18. Kaptchuk T.J., Edwards R.A., Eisenberg D.M. Complementary medicine: efficacy beyond the placebo effect. Ernst E. Complementary medicine: an objective appraisal. 1996;42-70 Butterworth-Heinemann, Oxford.
19. Last J.M. A dictionary of epidemiology. 1988;Oxford University Press, New York.
20. Aaronson N.K., Meyerowitz B.E., Bard M., et al. Quality of life research in oncology. Past achievements and future priorities. Cancer. 67:1991;839-843.
21. Ho R.C. The future direction of clinical trials. Cancer. 74:1994;2739-2744.
22. Ernst E., White A.R. Acupuncture for back pain: a meta-analysis of randomized controlled trials. Arch Intern Med. 158:1998;2235-2241.
23. Koes B.W., Assendelft W.J., van der Heijden G.J., Bouter L.M. Spinal manipulation for low back pain. An updated systematic review of randomized clinical trials. Spine. 21:1996;2860-2871.
24. Burzynski S.R., Kubove E. Initial clinical study with antineoplaston A2 injections in cancer patients with five years' follow-up. Drugs Exp Clin Res. (suppl 1):1987;1-12.
25. Cassileth B.R., Chapman C.C. Alternative and complementary cancer therapies. Cancer. 77:1996;1026-1034.
26. Angell M., Kassirer J.P. Alternative medicine - The risks of untested and unregulated remedies. N Engl J Med. 339:1998;839-840.
27. Ezzo J., Berman B.M., Vickers A.J., Linde K. Complementary medicine and the Cochrane collaboration. J Am Med Assoc. 280:1998;1628-1630.
28. Kienle G.S., Kiene H. Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. Altern Ther Health Med. 2:1996;39-54.
29. Kiene H. A critique of the double-blind clinical trial. Part 1. Altern Ther Health Med. 2:1996;74-80.
30. Lindahl O., Lindwall L. Is all therapy just a placebo effect? Metamedicine. 3:1982;255-259.
31. Penick S.B., Fisher S. Drug-set interaction: psychological and physiological effects of epinephrine under differential expectations. Psychosom Med. 27:1965;177-182.
32. Rochon P.A., Binns M.A., Litner J.A., et al. Are randomized control trial outcomes influenced by the inclusion of a placebo group?: A systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment. J Clin Epidemiol. 52:1999;113-122.
33. Kiene H. A critique of the double-blind clinical trial. Part 2. Altern Ther Health Med. 2:1996;59-64.
34. Margolin A., Avants S.K., Kleber H.D. Investigating alternative medicine therapies in randomized controlled trials. J Am Med Assoc. 280:1998;1626-1628.
35. Streitberger K., Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet. 352:1998;364-365.
36. Vickers A., Cassileth B., Ernst E., et al. How should we research unconventional therapies? Int J Technol Assess Health Care. 13:1997;111-121.
37. Aldridge D. Single case research designs. Lewith G.T., Aldridge D. Clinical research methodology for complementary therapies. 1993;136-168 Hodder & Stoughton, London.
38. Kiene H., von Schon-Angerer T. Single-case causality assessment as a basis for clinical judgment. Altern Ther Health Med. 4:1998;41-47.
39. Lukoff D., Edwards D., Miller M. The case study as a scientific method for researching alternative therapies. Altern Ther Health Med. 4:1998;44-52.
40. Kaegi E. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. Unconventional therapies for cancer: 1. Essiac. Can Med Assoc J. 158:1998;897-902.
41. Liu W., Kato M., Akhand A.A., et al. The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases. Int J Oncol. 12:1998;1321-1326.